Samrat Pharmachem Ltd. - Research Center
530125 SAMRATPH Group (XT) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | |
|---|---|---|---|---|---|
| Sales | 80.82 | 82.68 | 61.67 | 79.74 | 57.48 |
| Operating profit | 2.58 | 1.36 | 0.11 | 0.23 | 0.77 |
| Interest | 0.19 | 0.11 | 0.23 | 0.13 | 0.22 |
| Gross profit | 2.98 | 1.55 | 0.30 | 0.40 | 0.91 |
| EPS (Rs) | 6.68 | 4.52 | 1.11 | -0.61 | 1.98 |
Quarterly
results in details
| Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | |
|---|---|---|---|---|---|
| Other income | 0.59 | 0.30 | 0.42 | 0.30 | 0.36 |
| Stock adjustment | -1.78 | 3.52 | -2.85 | 5.09 | -0.91 |
| Raw material | 78.16 | 75.42 | 62.30 | 72.11 | 55.65 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.50 | 0.66 | 0.56 | 0.51 | 0.49 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1.36 | 1.74 | 1.55 | 1.81 | 1.48 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 |
| Taxation | 0.75 | -0.01 | -0.20 | 0.43 | 0.14 |
| Net profit / loss | 2.07 | 1.40 | 0.34 | -0.19 | 0.61 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 3.20 | 1.64 | 0.18 | 0.29 | 1.34 |
| GPM (%) | 3.66 | 1.87 | .49 | .50 | 1.58 |
| NPM (%) | 2.54 | 1.68 | 0.55 | -0.24 | 1.06 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis